Clinical & Experimental Immunology · 1998 · 22 citations · 25 references
Life SciencesImmunologySurgeryApoptosisImmunoregulationInflammationAcute InflammationApoptosis In Immune CellsApoptosis In Tissue HomeostasisInflammatory BiomarkersInflammatory Response RegulationInflammatory SignalingFas LigandFas Ligand-mediated ApoptosisFas-associated Death Domain ProteinInflammatory Response To SurgeryInflammatory Response To Tissue InjuryInflammatory Tissue DamagePhysiological HomeostasisTissue Damage Mechanisms
FasL, which is expressed mainly on activated lymphocytes, can induce apoptosis (programmed cell death) of cells which express Fas. Fas/FasL interaction is primarily beneficial in maintaining immunological and physiological homeostasis by eliminating unnecessary cells. Dysregulation of the interaction, however, leads to tissue damage. We investigated how Fas/FasL levels changed after major surgery. The major aim of this study was to elucidate the involvement of the Fas/FasL system in postoperative inflammation. The investigation involved 10 patients admitted to the intensive care unit after surgery. Although the percentage of Fas+ cells and the amount of Fas expression tended to increase, there was no significant difference between pre- and post-operative samples. In contrast, the levels of FasL mRNA were dramatically up-regulated after operation. Post-operative C-reactive protein (CRP) levels increased and correlated well with FasL levels (r=0.91, P<0.01). Lymphocyte counts decreased after operation and were inversely proportional to FasL levels (r=0.58, P < 0.05). These results suggest that the enhanced FasL expression is likely to be related to systemic inflammatory responses induced during the perioperative period. FasL up-regulation may be involved in the aggravation of tissue damage, including lymphocytopenia, in the early post-operative period.
25
Development and validation of the State Hope Scale.
C. R. Snyder, Susie C. Sympson, Florence C. Ybasco et al. · Journal of Personality and Social Psychology · 1996 · 3.4K citations
Lethal effect of the anti-Fas antibody in mice
Jun Ogasawara, Rie Watanabe‐Fukunaga, Masashi Adachi et al. · Nature · 1993 · 1.9K citations
Life Sciences, Immunology, Pathology +14
Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand
Tomohiro Takahashi, Masato Tanaka, Camllynn I. Brannan et al. · Cell · 1994 · 1.5K citations
Life Sciences, Immunology, Pathology +12
Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation
S T Ju, D J Panka, Haili Cui et al. · Nature · 1995 · 1.5K citations